(Q38227748)

31 August 2017

title

The tumour microenvironment in B cell lymphomas (English)

1 reference

31 August 2017

David W Scott

1

1 reference

31 August 2017

Randy D Gascoyne

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

10 July 2014

1 reference

31 August 2017

published in

Nature Reviews Cancer

1 reference

31 August 2017

volume

14

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

517-534

1 reference

Pathogenesis of human B cell lymphomas

31 August 2017

cites work

1 reference

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

31 March 2020

1 reference

Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions

31 March 2020

1 reference

Foxp3+ follicular regulatory T cells control the germinal center response.

31 March 2020

1 reference

Macrophage plasticity and polarization: in vivo veritas

31 March 2020

1 reference

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.

31 March 2020

1 reference

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

31 March 2020

1 reference

Lymphoma dissemination: the other face of lymphocyte homing

31 March 2020

1 reference

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination

31 March 2020

1 reference

Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma

31 March 2020

1 reference

Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs.

31 March 2020

1 reference

Relative distribution of tumour cells and reactive cells in follicular lymphoma.

31 March 2020

1 reference

Tumor cell dissemination in follicular lymphoma

31 March 2020

1 reference

Germinal center reutilization by newly activated B cells

31 March 2020

1 reference

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

31 March 2020

1 reference

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells

31 March 2020

1 reference

Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma

31 March 2020

1 reference

Aberrant expression and reverse signalling of CD70 on malignant B cells

31 March 2020

1 reference

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

31 March 2020

1 reference

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes.

31 March 2020

1 reference

The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours

31 March 2020

1 reference

Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.

31 March 2020

1 reference

Chronic B cell malignancies and bone marrow microenvironment

31 March 2020

1 reference

The biology of Hodgkin's lymphoma

31 March 2020

1 reference

The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori

31 March 2020

1 reference

Hodgkin's disease: establishment and characterization of four in vitro cell lies

31 March 2020

1 reference

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

31 March 2020

1 reference

Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer

31 March 2020

1 reference

PI3 kinase signals BCR-dependent mature B cell survival

31 March 2020

1 reference

Mechanisms of B-cell lymphoma pathogenesis

31 March 2020

1 reference

Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype

31 March 2020

1 reference

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

31 March 2020

1 reference

Self-antigen recognition by follicular lymphoma B-cell receptors

31 March 2020

1 reference

Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen

31 March 2020

1 reference

Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.

31 March 2020

1 reference

Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity

31 March 2020

1 reference

Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases

31 March 2020

1 reference

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

31 March 2020

1 reference

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins

31 March 2020

1 reference

Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma

31 March 2020

1 reference

Early steps of follicular lymphoma pathogenesis

31 March 2020

1 reference

Follicular lymphoma and the immune system: from pathogenesis to antibody therapy

31 March 2020

1 reference

31 March 2020

1 reference

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

31 March 2020

1 reference

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

31 March 2020

1 reference

Oncogenically active MYD88 mutations in human lymphoma

31 March 2020

1 reference

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

31 March 2020

1 reference

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas

31 March 2020

1 reference

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

31 March 2020

1 reference

Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance

31 March 2020

1 reference

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

31 March 2020

1 reference

IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma

31 March 2020

1 reference

Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling.

31 March 2020

1 reference

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

31 March 2020

1 reference

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

31 March 2020

1 reference

Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma

31 March 2020

1 reference

Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease

31 March 2020

1 reference

Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness

31 March 2020

1 reference

Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.

31 March 2020

1 reference

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand

31 March 2020

1 reference

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

31 March 2020

1 reference

Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis

31 March 2020

1 reference

Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways

31 March 2020

1 reference

Essential role of stromally induced hedgehog signaling in B-cell malignancies

31 March 2020

1 reference

Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.

31 March 2020

1 reference

Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma.

31 March 2020

1 reference

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

31 March 2020

1 reference

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

31 March 2020

1 reference

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

31 March 2020

1 reference

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

31 March 2020

1 reference

Analysis of the coding genome of diffuse large B-cell lymphoma

31 March 2020

1 reference

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

31 March 2020

1 reference

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

31 March 2020

1 reference

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

31 March 2020

1 reference

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

31 March 2020

1 reference

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

31 March 2020

1 reference

Fas ligand expression in Hodgkin lymphoma.

31 March 2020

1 reference

Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy

31 March 2020

1 reference

Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.

31 March 2020

1 reference

Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma

31 March 2020

1 reference

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

31 March 2020

1 reference

Macrophage diversity enhances tumor progression and metastasis

31 March 2020

1 reference

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

31 March 2020

1 reference

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

31 March 2020

1 reference

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

31 March 2020

1 reference

Stromal gene signatures in large-B-cell lymphomas

31 March 2020

1 reference

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

31 March 2020

1 reference

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

31 March 2020

1 reference

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

31 March 2020

1 reference

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

31 March 2020

1 reference

The immune contexture in human tumours: impact on clinical outcome

31 March 2020

1 reference

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.

31 March 2020

1 reference

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

31 March 2020

1 reference

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

31 March 2020

1 reference

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

31 March 2020

1 reference

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols

31 March 2020

1 reference

Implications of the tumor microenvironment on survival and disease response in follicular lymphoma

31 March 2020

1 reference

Pathogenesis of follicular lymphoma

31 March 2020

1 reference

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

31 March 2020

1 reference

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

31 March 2020

1 reference

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

31 March 2020

1 reference

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

31 March 2020

1 reference

The role of tumour-stromal interactions in modifying drug response: challenges and opportunities

31 March 2020

1 reference

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells

31 March 2020

1 reference

Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting

31 March 2020

1 reference

Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance

31 March 2020

1 reference

Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a

31 March 2020

1 reference

A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas

31 March 2020

1 reference

Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas

31 March 2020

1 reference

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

31 March 2020

1 reference

Active and passive immunotherapy for lymphoma: proving principles and improving results

31 March 2020

1 reference

Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.

31 March 2020

1 reference

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies

31 March 2020

1 reference

Sensitizing protective tumor microenvironments to antibody-mediated therapy

31 March 2020

1 reference

Angiogenesis in cancer and other diseases

31 March 2020

1 reference

The role of angiogenesis in human non-Hodgkin lymphomas

31 March 2020

1 reference

Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes

31 March 2020

1 reference

Prognostic significance of VEGF, VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy

31 March 2020

1 reference

Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).

31 March 2020

1 reference

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.

31 March 2020

1 reference

Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes

31 March 2020

1 reference

Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia

31 March 2020

1 reference

Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists

31 March 2020

1 reference

Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling

31 March 2020

1 reference

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

31 March 2020

1 reference

Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

31 March 2020

1 reference

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

31 March 2020

1 reference

Genetics of follicular lymphoma transformation

31 March 2020

1 reference

Homing and cellular traffic in lymph nodes

31 March 2020

1 reference

Stromal cell contributions to the homeostasis and functionality of the immune system.

31 March 2020

1 reference

The who, how and where of antigen presentation to B cells

31 March 2020

1 reference

Molecular programming of B cell memory

31 March 2020

1 reference

A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center

31 March 2020

1 reference

The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers

31 March 2020

1 reference

The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry

31 March 2020

1 reference

Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter

31 March 2020

1 reference

Clonal selection in the germinal centre by regulated proliferation and hypermutation

31 March 2020

1 reference

Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

31 March 2020

1 reference

Molecular pathogenesis of mantle cell lymphoma

31 March 2020

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

31 March 2020

1 reference

Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas

31 March 2020

1 reference

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

31 March 2020

1 reference

Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue

31 March 2020

1 reference

MALT lymphoma: from morphology to molecules

31 March 2020

1 reference

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

31 March 2020

1 reference

Genetic heterogeneity of diffuse large B-cell lymphoma

31 March 2020

1 reference

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

31 March 2020

1 reference

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

31 March 2020

1 reference

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.

31 March 2020

1 reference

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

31 March 2020

1 reference

The genetic landscape of mutations in Burkitt lymphoma

31 March 2020

1 reference

Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma

31 March 2020

1 reference

Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497

31 March 2020

1 reference

Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma

31 March 2020

1 reference

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma

31 March 2020

1 reference

Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients

31 March 2020

1 reference

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

31 March 2020

1 reference

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

31 March 2020

1 reference

A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy

31 March 2020

1 reference

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

31 March 2020

1 reference

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

31 March 2020

1 reference

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

31 March 2020

1 reference

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

31 March 2020

1 reference

Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.

31 March 2020

1 reference

Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma.

31 March 2020

1 reference

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

31 March 2020

1 reference

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

31 March 2020

1 reference

Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma

31 March 2020

1 reference

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

31 March 2020

1 reference

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

31 March 2020

1 reference

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

31 March 2020

1 reference

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

31 March 2020

1 reference

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

31 March 2020

1 reference

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

31 March 2020

1 reference

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers

31 March 2020

1 reference

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

31 March 2020

1 reference

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial

31 March 2020

1 reference

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

31 March 2020

1 reference

Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas

31 March 2020

1 reference

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study

31 March 2020

1 reference

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

31 March 2020

1 reference

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

31 March 2020

1 reference

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.

31 March 2020

1 reference

Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results

31 March 2020

1 reference

Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma

31 March 2020

1 reference

Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens

31 March 2020

1 reference

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.

31 March 2020

1 reference

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.

31 March 2020

1 reference

High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes

31 March 2020

1 reference

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

31 March 2020

1 reference

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

31 March 2020

1 reference

The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement

31 March 2020

1 reference

Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation

31 March 2020

1 reference

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma

31 March 2020

1 reference

The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.

31 March 2020

1 reference

12 December 2020

Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones

1 reference

12 December 2020

Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system

1 reference

12 December 2020

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

1 reference

12 December 2020

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3774

1 reference

Dimensions Publication ID

31 August 2017

1047004125

0 references

1 reference